Cboe CA - Delayed Quote CAD
Merck & Co., Inc. (MRK.NE)
18.28
+0.16
+(0.88%)
At close: April 24 at 3:18:03 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
21,468,000
21,468,000
13,006,000
19,095,000
14,109,000
Investing Cash Flow
-7,734,000
-7,734,000
-14,083,000
-4,960,000
-16,555,000
Financing Cash Flow
-7,032,000
-7,032,000
-4,810,000
-9,119,000
2,593,000
End Cash Position
13,318,000
13,318,000
6,909,000
12,773,000
8,167,000
Capital Expenditure
-3,372,000
-3,372,000
-3,863,000
-4,388,000
-4,448,000
Issuance of Debt
3,599,000
3,599,000
5,939,000
--
7,936,000
Repayment of Debt
-1,290,000
-1,290,000
-1,755,000
-2,251,000
-2,319,000
Repurchase of Capital Stock
-1,306,000
-1,306,000
-1,346,000
--
-840,000
Free Cash Flow
18,096,000
18,096,000
9,143,000
14,707,000
9,661,000
12/31/2021 - 2/4/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NVON.NE NOVO NORDISK CDR (CAD HEDGED)
6.73
+2.75%
ROG.NE Roche Holding AG
20.82
+2.36%
JNJ.NE JOHNSON & JOHNSON CDR (CAD HEDG
20.44
-0.20%
PFE.NE Pfizer Inc.
10.50
+2.24%
LLY.NE Eli Lilly and Company
31.75
+3.66%
DSNKY Daiichi Sankyo Company, Limited
23.50
+1.34%
BAYRY Bayer Aktiengesellschaft
6.43
-0.46%
GSK GSK plc
37.50
+1.27%
NVS Novartis AG
111.17
+0.94%
AMRN Amarin Corporation plc
11.18
+7.92%